KARACHI: The Centre for Regenerative Medicine and Stem Cell Research (CRM) of Aga Khan University (AKU) has won a Rs14.5 million grant to develop new, targeted therapies for a common form of blood cancer in adults; Philadelphia chromosome positive (Ph+) leukaemia.

“We aim to combine approaches in molecular medicine and stem cell therapy to create a more precise form of treatment that has the potential to be more convenient for the patient since it will only require a single administration,” says Dr Afsar Mian, the principal investigator of the study.

“We are anticipating that once introduced, the stem cells will grow and multiply in the body and continuously release the therapeutic peptide to target the cancer cells, inhibit their growth and ultimately cure the disease.”

Existing medicines for Ph+ leukaemia are currently proving to be less effective due to growing drug resistance and the problem of side effects. Also, they require life-long use by the patient and do not lead to complete eradication of the disease.

This innovative use of stem cells will also generate evidence on the use of peptides to provide targeted treatment in other types of cancers. In the future, Dr Mian and his team seek to combine their expertise in cancer research as well as drug design and delivery to see if such approaches can be used to treat other diseases.

The grant was awarded by the Higher Education Commission of Pakistan’s (HEC) flagship National Research Programme for Universities.

Published in Dawn, January 21st, 2021

Opinion

Editorial

Judiciary in the dock
Updated 22 Feb, 2025

Judiciary in the dock

Recent developments in SC and IHC certainly seem to have lent credibility to perception that judges perceived as a 'threat’ are being sidelined.
Paying taxes
22 Feb, 2025

Paying taxes

FINANCE Minister Muhammad Aurangzeb’s ‘hard talk’ at a retail business conference on Thursday was long ...
Rules for thee
22 Feb, 2025

Rules for thee

IT was a year ago when, in the tumultuous aftermath of the 2024 elections, the state banned X. Today, it remains...
Ukraine initiative
Updated 21 Feb, 2025

Ukraine initiative

Whether Trump’s Ukraine peace initiative succeeds or not, it will be difficult for Kyiv, Europe to face Russian military machine without US support.
High cost of SOEs
21 Feb, 2025

High cost of SOEs

THERE are losses and then some. The finance ministry’s latest overview of the federally owned state enterprises...
Poor impression
21 Feb, 2025

Poor impression

RECENT developments in the Senate have provided cause for concern on how parliamentary business is being conducted....